Article
Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3xTg-AD mice and MC65 cells.
CNS neuroscience & therapeutics - 1 Nov 2014
Revilla Susana, Ursulet Suzanna, Álvarez-López María Jesús, Castro-Freire Marco, Perpiñá Unai, García-Mesa Yoelvis, Bortolozzi Analía, Giménez-Llort Lydia, Kaliman Perla, Cristòfol Rosa, Sarkis Chamsy, Sanfeliu Coral
Abstract excerpt
AIMS: Glial cell-derived neurotrophic factor (GDNF) is emerging as a potent neurotrophic factor with therapeutic potential against a range of neurodegenerative conditions including Alzheimer's disease (AD). We assayed the effects of GDNF treatment in AD experimental models through gene-therapy procedures. METHODS: Recombinant lentiviral vectors were used to overexpress GDNF gene in hippocampal astrocytes of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
